RXST
Rxsight IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$251.90M
P/E Ratio
—
EPS
$-1.13
Beta
1.24
52W High
$16.48
52W Low
$5.30
50-Day MA
$6.70
200-Day MA
$8.66
Dividend Yield
—
Profit Margin
-36.60%
Forward P/E
116.28
PEG Ratio
—
About Rxsight Inc
Rxsight Inc. is a pioneering healthcare technology company dedicated to transforming vision correction through advanced diagnostic and surgical solutions in refractive eye surgery. Utilizing proprietary software and precision-guided laser systems, Rxsight aims to significantly improve patient outcomes and quality of life for those seeking vision correction. The firm maintains a robust intellectual property portfolio and cultivates strategic partnerships, positioning itself strongly within the expanding ophthalmic market. With a commitment to innovation and operational excellence, Rxsight is poised for considerable growth and a transformative impact within the eye care sector.
Fundamentals
| Revenue (TTM) | $127.48M |
| Gross Profit (TTM) | $98.18M |
| EBITDA | $-52.02M |
| Operating Margin | -57.70% |
| Return on Equity | -17.10% |
| Return on Assets | -11.20% |
| Revenue/Share (TTM) | $3.10 |
| Book Value | $6.68 |
| Price-to-Book | 0.94 |
| Price-to-Sales (TTM) | 1.98 |
| EV/Revenue | 0.35 |
| EV/EBITDA | -7.70 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -18.50% |
| Shares Outstanding | $41.40M |
| Float | $39.18M |
| % Insiders | 5.66% |
| % Institutions | 93.26% |
Historical Volatility
HV 10-Day
49.86%
HV 20-Day
75.82%
HV 30-Day
68.07%
HV 60-Day
64.17%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($8.79 target)
1
Strong Buy6
Hold2
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026